Gunagratinib

DB18191ExperimentalSmall molecule

Gunagratinib: Overview.

Mechanism: Pharmacologically active on Fibroblast growth factor receptor
Curator reviewed
Formula / weight: C₂₂H₂₅N₅O₄ · 423.473 g/mol (avg)
Also known as: (s)-1-(1-acryloylpyrrolidin-3-yl)-3-((3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1h-pyrazole-4-carboxamide · 1h-pyrazole-4-carboxamide, 3-(2-(3,5-dimethoxyphenyl)ethynyl)-5-(methylamino)-1-((3s)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)-

Resolves to

Compound

Structure

InChIKeyQFUIJOBJAQBGDH-HNNXBMFYSA-NSMILESCNC1=C(C(N)=O)C(=NN1[C@H]1CCN(C1)C(=O)C=C)C#CC1=CC(OC)=CC(OC)=C1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Gunagratinib, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.